Albany, NY , Jan. 27, 2016 -- Transparency Market Research has published a new report on the rapid medical diagnostics kits market that discusses its stance in the global setting. The research report, titled “Rapid Medical Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019,” offers an evaluation of the market in a political, economic, social, technological, legal, and environmental context. The report has also used a SWOT analysis and Porter’s five forces analysis to determine the factors governing the trajectory of this market in the near future. According to the research report, the global rapid medical diagnostic kits market was valued at US$17.65 bn in 2012. The market is expected to register a CAGR of 5.5% through the forecast period to reach a value of US$25.76 bn by the end of 2019.
Browse Report on Rapid Medical Diagnostic Kits Market: http://www.transparencymarketresearch.com/rapid-medical-diagnostic-kits.html
The global rapid medical diagnostic kits market is segmented on the basis of application, technology, and geography. On the basis application, the market is divided into clinical testing, home-use, and veterinary. The clinical testing and home-use segments are further sub-segmented into infectious disease testing, cholesterol monitoring, substance abuse testing, fertility and pregnancy testing, and blood glucose testing. The technologies used in this market are lateral flow, flow-through, solid-phase, and agglutination assays.
The market study, titled “Rapid Medical Diagnostic Kits Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019”, makes for an informative report, having in-depth analysis of past performances, current trends, and future prospects of the global rapid medical diagnostic kits market.
Research Study on Rapid Medical Diagnostic Kits Market:
The market for rapid medical diagnostic kits is witnessing an exceptional growth curve globally due to the continuous rise in demand for precautionary management of communicable ailments. Since its inception, rapid medical diagnostic kits are becoming an imperative segment of the medical diagnostics market and the potential of this market has been continually increasing in terms of detectable ailments and approval by end users.
This research report studies the global rapid medical diagnostic kits market on three major fronts, namely technologies, application areas, and region.
Avail a Sample Copy of Research Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1301
The rapid medical diagnostic kits market, based on application, has been further classified into three categories such as home-use, clinical testing, and veterinary diagnostics. In addition to this, the rapid medical diagnostic kits market, based on technology, has been classified into flow-through, solid phase, lateral flow, and agglutination assays. Every segment is evaluated considering its market size for the period between 2011 and 2019. This also consists of the market insights and predictions for the rapid medical diagnostic kits industry in terms of CAGR for the period from 2013 to 2019, determining 2012 as the base year.
Regionally, the rapid medical diagnostic kits market is classified into four markets, which are North America, Europe, Asia Pacific and Rest of the World. The future estimation during the period of 2013 to 2019 for each of these markets has been incorporated in this report.
The rapid medical diagnostic kits market overview presents the qualitative analysis of the market dynamics of the global market for rapid medical diagnostic kits, and hence, it consists of information about the market growth drivers, limitations, opportunities, Porter's five forces model, and market magnetism of this industry.
Trending Report by Transparency Market Research:
- Pain Management Devices Market: http://www.transparencymarketresearch.com/pain-management-drugs-devices.html
- Patient Warming Devices Market: http://www.transparencymarketresearch.com/patient-warming-devices-market.html
About Us:
Transparency Market Research (TMR) is a U.S. based provider of syndicated research, customized research, and consulting services. TMR’s global and regional market intelligence coverage includes industries such as pharmaceutical, chemicals and materials, technology and media, food and beverages, and consumer goods, among others. Each TMR research report provides clients with a 360-degree view of the market with statistical forecasts, competitive landscape, detailed segmentation, key trends, and strategic recommendations.
Mr. Sudip.S 90 State Street, Suite 700 Albany, NY 12207 United States. Tel: +1-518-618-1030 USA - Canada Toll Free: 866-552-3453 Email: [email protected] Website: http://www.transparencymarketresearch.com Blog: http://www.tmrblog.com/


Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Washington Post Publisher Will Lewis Steps Down After Layoffs
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Instagram Outage Disrupts Thousands of U.S. Users
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment 



